MPX Bioceutical (MPX) Stock Price, News & Analysis

Company Overview

MPX Bioceutical Corporation is a multinational diversified cannabis company focused on the medical and adult use cannabis markets. The company has a growing presence in the U.S. with imminent plans for ten dispensaries and four production facilities in four states. It also has a production facility under construction in Canada as well as a pending licence application to Health Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MPX Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of MPX Bioceutical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MPX Bioceutical investors own include CAMP4 Therapeutics (CAMP), Canopy Growth (CGC), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Nemaska Lithium (NMX), Unrivaled Brands (TRTC) and CrowdStrike (CRWD).

Industry, Sector and Symbol

• Stock Exchange: CNSX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Cannabis
• Current Symbol: CNSX:MPX
• CIK: N/A
• Web: canadianbioceutical.com
• Phone: +1-416-840-3725
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A